You don't have to travel all the way to Peru to see something as amazing as the Nazca Lines. There is a similar ancient site in California.
Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a phase 2 trial. The Bay Area-based biotech unveiled its ambition earlier ...
Maze seeks as much as $133 mln in New York IPO Backers include Alphabet's GV and Third Rock Ventures Biotech IPOs set for ramp up in coming weeks Jan 27 (Reuters) - Drug developer Maze ...
BOULDER CITY, Nev. — An additional $20 million has been awarded to the Topock Marsh to address long-standing issues with its water delivery system, supplementing a previous $20 million ...